AMPH AMPHASTAR PHARMACEUTICALS IN
2026Q1 · CUSIP 03209R103 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
212
Δ holders QoQ
-22
Breadth percentile
Top 93%
Whale holders
116
Δ whales
-11
Inst. holding value
$626M
New positions
30
Closed positions
52
Price momentum (1Q)
-39.5%
Put / Call
0/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2023Q2 | Top 7% | +0.5% | -1.0% |
| 2022Q2 | Top 6% | -12.8% | +0.1% |
| 2022Q1 | Top 4% | -10.8% | -21.0% |
| 2021Q4 | Top 16% | +28.5% | +22.3% |
| 2020Q2 | Top 15% | -5.5% | -8.7% |
| 2018Q4 | Top 8% | -12.3% | -9.0% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
2
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
11.8
EPS (TTM)
$1.66
EPS YoY
-39.9%
Revenue (TTM)
$0.7B
Revenue YoY
-1.4%
Net margin
11.0%
ROE
10.2%
Debt ratio
53.1%
FCF (TTM)
$135M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.